Firebrick Pursues Development of Nasodine for Use in Children
Posted: 23 February 2023 Firebrick Pharma announced plans to develop Nasadine Nasal Spray for use in children as well as adults. The plans were outlined in a Paediatric Investigation Plan (PIP) that was filed with the European Medicines…
Clinical program with the Lambert Initiative Expands to include Avecho’s Oral Cannabidiol
Posted: 22 February 2023 Avecho Biotechnology Limited has today announced that its ongoing collaboration with leading Australian research group for cannabinoid therapeutics, the Lambert Initiative at the University of Sydney, will expand to include a series of clinical…
Monash Health’s Victorian Heart Hospital officially launches
Posted: 21 February 2023 The latest addition to the Monash Health group of hospitals was opened. The Victorian Heart Hospital was officially launched by the Victorian Premier Daniel Andrews and Minister for Health Mary-Anne Thomas. In partnership…
Medication for potential treatment of anxiety disorders and postpartum depression to progress to next stage of clinical trials
Posted: 21 February 2023 A unique drug delivery technology designed to enable the oral administration of certain therapeutics with low oral bioavailability has reached another exciting milestone with ‘LYT-300’ (oral allopregnanolone) set to enter a placebo-controlled, Phase 2a,…
In an Australian first clinical trial, Cyban demonstrates non-invasive brain monitor delivers equivalent results to invasive ICP monitoring to offer simple and safe alternative in treating critical brain injuries
Posted: 16 February 2023 A major milestone in the detection and management of brain injuries has been reached thanks to an Australian first clinical trial by Cyban which has demonstrated that the company’s patented technology is able to…
CSIRO researchers use machine learning to advance Alzheimer’s research
Posted: 15 February 2023 Researchers from CSIRO and QUT use “fake” MRIs developed via artificial intelligence to assess methods used in critical Alzheimer’s research. Scientists from CSIRO, Australia’s national science agency, in partnership with Queensland University of Technology,…
Antibiotic innovation helps fight against superbugs
Posted: 15 February 2023 RMIT scientists have created a new type of antibiotic that can be rapidly re-engineered to avoid resistance by dangerous superbugs. Developed by PhD candidate Priscila Cardoso and principal supervisor Dr Céline Valéry from the…
Biotech partnership to develop new therapies
Posted: 15 February 2023 La Trobe University researchers will collaborate with several industry and university partners, to develop ‘customised exosomes’ that have the potential to treat a wide range of diseases, including traumatic brain injury and retinal disease.…
RMIT first Victorian university to win Cygnet Award
Posted: 13 February 2023 RMIT is the first Victorian university to be awarded a SAGE Cygnet Award, just the third Cygnet Award to be given nationally. The SAGE Cygnet Award has been awarded to RMIT for work to…
Funding backs world-first test to detect ‘insidious’ malaria infections
Posted: 13 February 2023 Research to develop and deploy a world-first diagnostic test that could accelerate malaria eradication has been bolstered with over $1.3 million in new funding from the National Health and Medical Research Council (NHMRC). Two…
Hypertensives may benefit from gut microbial metabolites
Posted: 13 February 2023 Hypertension—high blood pressure—is a leading cause of death worldwide. Four out of five hypertensive patients have uncontrolled blood pressure despite clinical and lifestyle therapy, suggesting new approaches are needed. Over the past decade, experimental…
Fruit flies help researchers decode genetic link to Alzheimer’s disease
Posted: 13 February 2023 Researchers have used fruit flies to decipher an unexplained connection between Alzheimer’s disease and a genetic variation, revealing that it causes neurons to die. The findings from the WEHI-led team uncover a possible cause…
